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ABSTRACT 
It is widely believed that benign prostatic hyperplasia (BPH) is 
associated with aging. Thus, the question arises whether or not a 
correlation exists between the well known prostatic androgen and 
estrogen accumulation and aging. To address this question, we meas- 
ured 5a-dihydrotestosterone (DHT), testosterone, estradiol, and es- 
trone in epithelium and stroma of six normal (NPR) and 19 BPH and 
correlated the values with the age of the donors (26-87 yr). The mean 
DHT level in NPR epithelium was significantly higher than in NPR 
stroma, and also significantly higher than in epithelium and stroma of 
BPH. The epithelial DHT level of NPR and BPH decreased with age, 
the correlation being statistically significant. The stromal DHT level 
of NPR and BPH showed no correlation with age. Concerning testos- 
terone, generally rather low values were found which showed no cor- 
relation with age. The mean levels of estradiol and estrone were 
significantly higher in BPH stroma as compared to BPH epithelium 
as well as to NPR epithelium and stroma. In NPR, the mean levels of 
estradiol and estrone were significantly higher in epithelium than 
stroma. In NPR and BPH, the stromal estradiol and estrone levels 
increased significantly with age. In epithelium such a correlation be- 
tween the estrogen levels and age was not found. Our results indicate 
that the prostatic accumulation of DHT, estradiol, and estrone is in 
part intimately correlated with aging, leading with increasing age to a 
dramatic increase of the estrogen/androgen ratio particularly in stroma 
of BPH. (J Clin Endocrinol Metab 77: 375-381, 1993) 
C linical trials are currently underway to lower the intra- cellular level of Sa-dihydrotestosterone (DHT) and/or 
estrogens in benign prostatic hyperplasia (BPH) (1). The 
rational background for such clinical trials is the assumption 
that androgens are somehow involved in the development 
of BPH. In line herewith is the well documented finding that 
in BPH a manifold higher content of DHT as well as of 
estradiol and estrone is present than in the corresponding 
plasma and skeletal muscle (2, 3). 
However, the tremendous enrichment of DHT in whole 
tissue homogenate of BPH seems to be not a BPH specific 
phenomenon since nearly the same content has been found 
more recently in normal prostates (NPR) (4-7). But, lacking 
differences of DHT content in whole tissue homogenate from 
BPH and NPR do not exclude possible differences in DHT 
content between epithelium and stroma within the individual 
prostate as well as between NPR and BPH. Such differences 
could merit special interest because the embryonic stroma is 
essential for morphogenesis and growth of the rodent pros- 
tate. Furthermore, the mesenchyme rather than the epithe- 
lium is the major target for androgens (8, 9). Moreover, it 
has been postulated that in BPH an embryonic reawakening 
of the inductive potential of the prostatic stroma might occur 
(10). 
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As yet, however, only a limited number of studies on DHT 
content in epithelium and stroma of NPR and BPH has been 
performed. The available data are rather inconsistent (7, 1 l- 
14). The same holds true for the estrogen content in BPH 
and NPR. As yet, it is unclear whether or not a BPH specific 
accumulation of estrogens occurs (3, 6). However, within the 
BPH it has been shown that the stroma contains about three 
times more estrone and estradiol than the epithelium (15). 
This is in keeping with the preferential detection of estrogen 
receptors in stroma of BPH (16, 17). Therefore, it appears 
that the stromal compartment is the primary target for estro- 
genie action. 
Although the development of BPH is associated with aging 
(18), as yet, it is only known that the DHT content measured 
in whole BPH tissue homogenates, does not correlate with 
age (4, 6). Corresponding age related studies on androgen 
and estrogen content in epithelium and stroma of NPR and 
BPH are still lacking. 
Materials and Methods 
Chemicals 
[“HIDHT (SA, 4.32 TBq/mmol), testosterone (SA, 6.66 TBq/mmol), 
estrone (SA, 3.14 TBq/mmol), and estradiol (SA, 6.25 TBq/mmol) were 
purchased from New England Nuclear (Boston, MA). Antisera to DHT, 
testosterone, estradiol, and estrone were kindly provided by Schering 
AG (Berlin, Germany). Bond-elut columns (ODS, RI’), eluent for high 
performance liquid chromatography (fWLC) and scintillation solution 
Ready-Solv HP were obtained from Inter Sciences (Frankfurt, Germany), 
Baker (Grog Gerau, Germany), and Beckman (Munich, Germany), re- 
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spectively. All other chemicals were obtained from Merck AC (Darms- 
tadt, Germany), Serva (Heidelberg, Germany), Ferak (Berlin, Germany), 
and Boehringer (Mannheim, Germany). 
Tissue preparation 
NPR tissue was obtained from 6 brain-dead kidney donors, aged 26- 
61 yr, Immediately after nephrectomy, the pelvis was chilled with ice 
and the prostate was removed within 30 min. BPH tissue was obtained 
from 19 men, aged 64-87 yr, removed by suprapubic prostatectomy. 
For each donor a written consent for this study was given. The exstir- 
pated tissue was immediately chilled in ice-cold 0.9% NaCI, cut into 
small pieces, and stored at -196 C. Each tissue specimen was histolog- 
ically proven. 
Epithelium and stroma were separated mechanically from each other 
and homogenized as previously described (17). Acid phosphatase and 
hydroxyproline were measured as markers for epithelial and stromal 
elements, respectively. The data were nearly identical to those published 
earlier (19-21). In the present study the mean relative purity of epithelial 
and stromal fractions ranged from 81-949;. 
Steroid extraction and defatting 
Immediately before extraction of endogenous steroids, 2000 dpm [‘H] 
DHT, testosterone, estradiol, and estrone, each, were added to the 
homogenates, derived from 2-4 g prostatic tissue, for the determination 
of steroid recovery. Steroids were extracted by ethyl ether, that has been 
added to the homogenates twice. The combined eiher phases were dried 
under nitrogen and redissolved in 10 ml methanol:HzO mixture (20:80; 
vol/vol). For defatting, the redissolved aliquots were passed through a 
Bond-elut column. The elution was performed with 3 ml methanol. The 
eluates were dried under nitrogen and redissolved in 1 ml acetoni- 
trile:HZO mixture (20:80; vol/vol). 
Separation of steroids by HPLC’ 
The redissolved steroids were separated from each other by reversed 
phase HPLC (Pharmacia-LKB; column: Spherisorb, RP18, 3 p, 250 mm’ 
4.6 mm, ODS II, Melz, Berlin, Germany). The steroids were eluted with 
a mixture of acetonitrile:water (vol/vol) using a gradient (19 min: 40:60; 
41 min: 50:50; 30 min: 40:60) at a flow rate of 1 ml/min. Fractions of 
0.5 ml were collected. Under these conditions DHT (capacity factor, 6.2), 
testosterone (3.5), estradiol(3.1), and estrone (5.0) were clearly separated 
from each other. 
Before routine assays were performed, several elution profiles of 
[‘H]DHT, testosterone, estradiol, and estrone, respectively, have been 
documented by measuring the radioactivity in each eluted fraction. The 
reproducibility of the profiles was excellent. Moreover, after each set of 
routine assays again an elution profile with the aforementioned tritiated 
steroids were recorded in order to confirm indirectly the effectiveness of 
steroid separation of the preceded runs. The eluted steroids (DHT, 
testosterone, estradiol, estrone) were dried under nitrogen and redis- 
solved in 600 ~1 methanol:gelatine phosphate buffer (10:50; vol/vol) 
and aliquoted for RIA. Up to this step, the mean recovery of [“HJDHT, 
testosterone, estradiol, and estrone, determined for each sample, was 
66%, 78%, 64%, and 81%, respectively, with less than +lO% deviation 
from run to run. 
RIA 
RIA was performed in duplicate. The redissolved aliquots were di- 
luted with gelatine phosphate buffer 1:20, 1:4, 1:2, 1:2 (vol/vol) for the 
quantification of DHT, testosterone, estradiol, and estrone, respectively. 
Then, aliquots of 200 ~1 were incubated with 100 ~1 antisera plus a 
constant amount of the respective tritiated steroid (dissolved in 100 ~1) 
for 12 h. The following cross-reactivities were given: DHT antiserum 
with testosterone: 42%; testosterone antiserum with DHT: 6.3%; estra- 
dial antiserum with estrone: 1.3%; and estrone antiserum with estradiol: 
3.2%. Bound/free-separation was performed with dextran coated char- 
coal. The bound fraction was analyzed in a scintillation counter. The 
standard curves were obtained as outlined elsewhere (3). The recovery 
of DHT, testosterone, estradiol, and estrone was 50%, 65%, 57%. and 
708, and the sensitivity of the standard curve (buffer blank + 2 SD) was 
8.0, 7.0, 2.6, and 2.1 pg/tube, respectively. Intraassay coefficient of 
variation (%; n = 5) of DHT, testosterone, estradiol, and estrone was 14, 
7, 7, and 2 at mean concentrations (picogram per g tissue) of 6600, 159, 
41, and 22, respectively. Interassay coefficient of variation (7;; n = 5) of 
DHT, testosterone, estradiol, and e&one amounted to 17, 7, 7, and 6 at 
mean concentrations (picogram per g tissue) of 6060, 191, 52, and SO, 
respectively. In all byproducts of the mechanical separation of epithe- 
hum and stroma, steroid concentrations were in the range of buffer 
blanks. 
Other methods 
Protein was determined according to Lowry rf al. (22) using BSA as 
standard. DNA was measured as described elsewhere (23). Acid phos- 
phatase (EC 3.1.3.2) was measured according to Walter and Schiitt (24). 
Hydroxyproline was measured as described previously (25). The results 
were analyzed by analysis of variance (ANOVA) with repeated meas- 
ures. In case of significance, descriptive Student’s t test was used 
additionally. P was considered significant at P < 0.05. Regression lines 
were calculated by the method of least squares. 
Results 
DHT and testosterone levels in epithelium and stroma of NPR 
and BPH 
Based on significances by ANOVA (P < 0.001) and on 
Student’s t test, the mean DHT concentration (Table 1) was 
significantly higher (P < 0.001) in epithelium than in stroma 
of NPR. It was also significantly higher (P at least <0.05) 
than in epithelium and stroma of BPH. In BPH significant 
differences in the DHT content between epithelium and 
stroma were not found. Concerning testosterone (Table l), 
no significant differences were found using ANOVA, al- 
though the mean testosterone concentration was higher in 
stroma than in epithelium of NPR. In BPH such difference 
between stroma and epithelium was only given when the 
values were based on DNA. 
Estradiol and estrone levels in epithelium and stroma of NPR 
and BPH 
Based on significances by ANOVA (P < 0.01) and on 
Student’s t test the mean estradiol concentration (Table 1) 
was significantly higher (P at least (0.05) in stroma than in 
epithelium of BPH. It was also significantly higher (P at least 
~0.05) than in epithelium and stroma of NPR. With regard 
to NPR, in epithelium higher estradiol levels were found, the 
difference being significantly (P < 0.01) when the values 
were based on protein. Concerning estrone (Table l), gen- 
erally the results were rather similar to those for estradiol. 
Correlation of DHT and testosterone levels with age 
In Fig. 1 DHT (upper ,~~anel) and testosterone levels (lower 
pn?lcI) were plotted against the age of donors. A significantly 
negative correlation (P at least <0.05) was found for DHT in 
epithelium of both the NPR and BPH. Moreover, a signifi- 
cantly negative correlation with age (P < 0.0001) was found 
when all DHT levels of the epithelium were taken together. 
In stroma, an age-dependent alteration of the DHT level was 
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TABLE 1. Mean @EM) endogenous concentration of DHT, testosterone, estradiol, and estrone in epithelium and stroma of NPR and BPH 
DHT 
Testosterone 
Estradiol 
NPR 
BPH 
NPR 
BPH 
NPR 
BPH 
Steroid concentration 
(fmmol/mg protein) (fnxd/mg DNA) 
n- 
Epithelium Stroma SEM Epithelium Stroma SEM A A 
6 1190 * 140 * 404 f 78 147 15900 f 1600 * 8200 51 1400 1410 
* * 
19 610 f  80 433 t 48 105 6900 f 110 8300 -c 800 1270 
5 19 f  2 37 k 6 6 267 k 49 748 + 60 78 
15 24 -r- 2 29 rt 4 6 308 c 18 599 I? 93 104 
6 4.4 c 0.3 * 2.2 k 0.3 05 61 f 6 49 + 14 11 
* 
19 3.5 f 0.4 * fi?, f 0.8 1.0 44 + 6 * 120 * 15 14 
Estrone NPR 5 4.1 + 0.4 * 0.9 t 0.2 0.6 58f 12 * 19 rt 5 14 
BPH 15 4.9 + 0.4 * ;4 
* 
* 0.9 0.8 60 k 6 * 147 f 18 17 
The star indicates a statisticallv (Student’s t test) significant difference. P < 0.05 was considered as significant. SEM A is the difference of SEM 
between epithelium and stroma. ” 
not found. Concerning the testosterone level, in no case an 
age-dependent alteration was found. 
Correlation of estradiol and estrone levels with age 
In Fig. 2 estradiol (upper palIe/) and estrone levels (lozuer 
panel) were plotted against the age of donors. A significantly 
positive correlation (P at least ~0.05) was found for estradiol 
as well as estrone in stroma of both NPR and BPH. Moreover, 
a significantly positive correlation with age (P < 0.0001) was 
found when all estradiol or estrone levels of the stroma were 
taken together. In epithelium, no significant age-dependent 
alteration of estradiol and estrone levels was found. 
Discussion 
In a previous comparative study between epithelium and 
stroma of NPR and BPH (20), we have shown that the mean 
potential DHT-forming capacity of 5a-reductase is highest 
in NPR epithelium. Furthermore, the epithelial DHT-forming 
capacity of 5cY-reductase decreases in a linear fashion with 
age, whereas in stroma the DHT-forming capacity of SLY- 
reductase remains unaltered over the whole age range (IS- 
86 yr). In excellent agreement with those study on 5a- 
reductase is the present comparative study on androgen 
levels indicating that 1) the mean endogenous DHT content 
is highest in NPR epithelium, and 2) a linear decrease of the 
DHT content occurs in epithelium with age, whereas in 
stroma the DHT content remains rather constant over the 
whole age range (26-87 yr). This agreement between 5a- 
reductase activity and endogenous DHT levels supports our 
concept that the 5cu-reductase plays an overwhelming role 
regarding the DHT accumulation in NPR and BPH (20, 21). 
As yet, published data on DHT content in epithelium and 
stroma from NPR and BPH differ markedly from one report 
to another and even within the individual studies if the DHT 
content is based either on wet weight, soluble protein, or 
DNA (7, 1 l-14). Therefore, to date it is completely uncertain 
whether a higher, identical, or lower DHT content is present 
in stroma as compared to epithelium. Probably, besides 
nonstandardized methodological procedures with respect to 
harvesting of prostates and their separation in epithelium 
and stroma, a further reason for those inconsistent mean 
DHT levels in the literature might be the significant impact 
of aging on the DHT content in epithelium as shown in this 
study. 
In regard to steroid levels and aging, as yet no systematic 
studies on epithelium and stroma of the human prostate 
were performed. It has only been reported that in unsepa- 
rated whole BPH tissue the DHT content does not correlate 
with age (3, 4, 6). Taking into account that the BPH consists 
mainly of stroma (26), a lacking correlation between DHT 
content in whole BPH tissue and age is not contradictory to 
our study, because in stroma we also were unable to dem- 
onstrate an age-dependent correlation. 
All in all, in stroma DHT levels appear to be similar over 
the whole age range, whereas in epithelium the rather high 
DHT level in young specimens decreases linearily with age. 
That is, in epithelium of the human prostate a DHT depri- 
vation with age occurs. Whether this age-dependent DHT 
deprivation in epithelium is causally linked to the fact that 
not the epithelium but the stroma becomes the major com- 
partment in BPH remains to be determined. Furthermore, in 
view of tendenciously different slopes of the regression lines 
for NPR and BPH specimens, at present the question remains 
unanswered whether the age-dependent decrease of DHT 
content in epithelium is solely due to aging per se or at least 
in part also due to BPH specific processes. Finally, despite 
an age-dependent decrease of DHT content in epithelium, 
our data clearly indicate that up to about 70 yr the epithelial 
DHT level is as high as in stroma, or even higher. 
Those high DHT levels are the target when treating BPH 
patients with 5cu-reductase inhibitor. In this respect, very 
recently it has been shown that such treatment of BPH 
patients causes a dramatic decrease of the intraprostatic DHT 
within a few days (27). This finding further supports our 
suggestion that the DHT accumulation in epithelium and 
stroma of the human prostate is mainly due to the intrapros- 
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FIG. 1. Correlation between endogenous 
DHT (upperpanel) and testosterone lev- 
els (lower panel) in epithelium and 
stroma of normal human prostate (0) 
and BPH (U) and the age of donors. The 
values are based either on protein (left) 
or on DNA (right). The significance of 
the age-related changes was determined 
by the coefficient of correlation (r). m, 
slope of those regression lines which 
were statistically significant (P at least 
CO.05). 
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tatic 5cu-reductase activity. However, the possible pathobiol- 
ogical role of the tremendous DHT accumulation in the 
human prostate, that seems to be neither stroma nor BPH 
specific, remains unclear. 
Besides the possible involvement of androgens in BPH 
development, numerous experiments indicate that estrogens 
might also be involved in the abnormal growth of the human 
prostate (1). In keeping with this assumption is the significant 
accumulation of estrone and estradiol in the human prostate 
when the levels are compared with those in plasma (3, 15, 
28) or in skeletal muscle (3). It is unclear, however, whether 
BPH tissue accumulates estrogens at a higher rate than NPR. 
So far, either identical (6) or significantly higher levels (3) 
were found in BPH than in NPR. Interestingly, in the latter 
study it has been further reported that BPH samples that 
were predominantly stromal hyperplasia frequently showed 
the highest estrogen levels. This observation is in agreement 
with another study in which estrogens are predominantly 
enriched in BPH stroma (15). The present study, including 
for the first time the measurement of estrogens in epithelium 
and stroma of NPR, confirms the aforementioned signifi- 
cantly higher estrogen accumulation in BPH stroma as com- 
pared to epithelium. According to our study, such striking 
difference in the mean estrogen level between epithelium 
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FIG. 2. Correlation between endogenous 
estradiol (upper panel) and estrone lev- 
els (lower panel) in epithelium and 
stroma of normal human prostate (0) 
and BPH (W) and the age of donors. The 
values are based either on protein (left) 
or on DNA (right). The significance of 
the age-related changes was determined 
by the coefficient or correlation (r). m, 
slope of those regression lines which 
were statistically significant (P at least 
<0.05). 
0 20 40 60 60 100 
7 
500 
z 400 
F 
1 
Stroma 
r - 0.67 r = 0.67 
m  = 2.3 m  5 6.6 = 00 g . 
- 200 
3 
z ‘O” 
; 
0 u n . 0 M 
0 20 40 60 60 100 0 20 40 60 60 100 
4~ Iw-I Age I yeas1 
7 500 
i5 
1 
Epithelium 
F 
400 
0 20 40 60 60 100 0 20 40 60 60 100 
Stroma 
500 
;i 
f.O.BB r = 0.79 
m  - 0.03 m  -0.40 g 
/ ;:I 
_,P . . lt .E -5 i2 zoo 
t loo 
0 
20 40 60 60 100 
Age I yeas1 Age I YeaSI 
Stroma 
r = 0.70 r -0.71 
m-O.64 m  = 7.2 , 
J . c . . Ti=Tzx- loo 
and stroma of BPH are due to the dramatic increase of the 
estradiol and estrone content with increasing age. In NPR 
stroma a similar age-dependent increase of the estrogen 
content occurs. However, despite this increase with age in 
NPR stroma the mean estradiol and estrone content remains 
significantly lower than in epithelium. 
In stroma of normal as well as hyperplastic prostate an 
age-dependent increase of estrone and estradiol content oc- 
curs. Thus, aging per se might have a specific impact on the 
estrogen accumulation in human prostate. Moreover, since 
the regression lines are considerably steeper for BPH than 
NPR, BPH specific processes might additionally be involved. 
In this respect, estrogen receptors have to be considered as 
one major candidate through which the estrogen accumula- 
tion is caused. Estrophilic proteins have been described in 
the human prostate (29). Furthermore, they seem to be 
preferentially located in BPH stroma (16,17). Besides estrogen 
receptors it is also conceivable that enzymes like aromatase 
(30, 31), steroid sulfate sulfatase (32), and 17&hydroxyste- 
roid dehydrogenase (33) are causally linked to estrogen ac- 
cumulation in human prostate. However, the actual cellular 
events leading to the asymmetric estrogen accumulation in 
epithelium and stroma of NRP and BPH are far from being 
understood. 
380 KRIEG ET AL. .I(‘E:CM.IS’li 
Finally, it is remarkable that the age-dependent decrease 
of DHT level in epithelium and the concomitant increase of 
estrone and estradiol level in stroma will lead to a tremen- 
dous increase with age of the estrogen/androgen ratio par- 
ticularly in the stroma of human prostate. That is, the poten- 
tial pathobiological role of estrogens for the human prostate 
could become stronger with age. This, in turn, could be of 
pathogenetic importance for BPH development if in fact a 
balanced estrogen/androgen synergism is necessary for in- 
tegrity and normal growth of the prostate (1). 
Regardless of whether androgens and estrogens act syn- 
ergistically or independently from each other in BPH, the 
high estrogen levels particularly in BPH stroma might justify 
the treatment of BPH patients with an aromatase inhibitor. 
Such trials, being currently underway, are promising due to 
animal experiments in which an aromatase inhibitor is in 
fact able to antagonize the estrogen-related stimulation of 
fibromuscular stroma in prostates from intact beagle dogs 
(34). However, the final outcome of treating BPH patients 
with aromatase inhibitors are as yet unknown 
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